Timing and Characteristics of Cumulative Evidence Available on Novel Therapeutic Agents Receiving Food and Drug Administration Accelerated Approval. (Q50597191)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Timing and Characteristics of Cumulative Evidence Available on Novel Therapeutic Agents Receiving Food and Drug Administration Accelerated Approval.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

11 June 2018

http://europepmc.org/abstract/PMC/5461381

Timing and Characteristics of Cumulative Evidence Available on Novel Therapeutic Agents Receiving Food and Drug Administration Accelerated Approval. (English)

1 reference

Europe PubMed Central

11 June 2018

http://europepmc.org/abstract/PMC/5461381

4

object named as

John P A Ioannidis

0 references

author name string

Huseyin Naci

1

1 reference

Europe PubMed Central

11 June 2018

http://europepmc.org/abstract/PMC/5461381

Olivier J Wouters

2

1 reference

Europe PubMed Central

11 June 2018

http://europepmc.org/abstract/PMC/5461381

Radhika Gupta

3

1 reference

Europe PubMed Central

11 June 2018

http://europepmc.org/abstract/PMC/5461381

language of work or name

0 references

publication date

1 June 2017

1 reference

Europe PubMed Central

11 June 2018

http://europepmc.org/abstract/PMC/5461381

Milbank Quarterly

1 reference

Europe PubMed Central

11 June 2018

http://europepmc.org/abstract/PMC/5461381

95

1 reference

Europe PubMed Central

11 June 2018

http://europepmc.org/abstract/PMC/5461381

2

1 reference

Europe PubMed Central

11 June 2018

http://europepmc.org/abstract/PMC/5461381

261-290

1 reference

Europe PubMed Central

11 June 2018

http://europepmc.org/abstract/PMC/5461381

Physicians' Knowledge About FDA Approval Standards and Perceptions of the "Breakthrough Therapy" Designation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Extensions of indication throughout the drug product lifecycle: a quantitative analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Use of surrogate outcomes in US FDA drug approvals, 2003-2012: a survey.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Characteristics of efficacy evidence supporting approval of supplemental indications for prescription drugs in United States, 2005-14: systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

The Strength of Association Between Surrogate End Points and Survival in Oncology: A Systematic Review of Trial-Level Meta-analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

How good is "evidence" from clinical studies of drug effects and why might such evidence fail in the prediction of the clinical utility of drugs?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005-2012.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Increasing value and reducing waste in research design, conduct, and analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Non-publication of large randomized clinical trials: cross sectional analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Innovating by developing new uses of already-approved drugs: trends in the marketing approval of supplemental indications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Power failure: why small sample size undermines the reliability of neuroscience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Characteristics of clinical trials to support approval of orphan vs nonorphan drugs for cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Accelerated approval of oncology products: the food and drug administration experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

The ClinicalTrials.gov results database--update and key issues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Issues in using progression-free survival when evaluating oncology products

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Contradicted and initially stronger effects in highly cited clinical research

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Accelerated approval of oncology products: a decade of experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Measuring inconsistency in meta-analyses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

A simple confidence interval for meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Comparison of evidence of treatment effects in randomized and nonrandomized studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

Therapeutic-class wars--drug promotion in a competitive marketplace

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 June 2018

FDA designations for therapeutics and their impact on drug development and regulatory review outcomes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

16 June 2018

A Randomized Trial Testing US Food and Drug Administration "Breakthrough" Language.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 August 2018

Drug development and FDA approval, 1938-2013.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 August 2018

Improving the drug development process: more not less randomized trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 August 2018

Mega-trials for blockbusters

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 August 2018

Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanercept

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 August 2018

Accelerated approval scrutinized: confirmatory phase 4 studies on new drugs languish

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 August 2018

A refined method for the meta-analysis of controlled clinical trials with binary outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461381

14 August 2018

Surrogate Endpoints And FDA’s Accelerated Approval Process

1 reference

https://api.crossref.org/works/10.1111%2F1468-0009.12261

21 January 2018

Why do we need some large, simple randomized trials?

1 reference

https://pubmed.ncbi.nlm.nih.gov/28589600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of incremental innovation in biopharmaceuticals: drug utilisation in original and supplemental indications

1 reference

https://pubmed.ncbi.nlm.nih.gov/28589600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/1468-0009.12261

1 reference

Europe PubMed Central

11 June 2018

http://europepmc.org/abstract/PMC/5461381

release_gxe3tnm745do5g7ae3udal7uwi

1 reference

https://api.fatcat.wiki/v0/release/gxe3tnm745do5g7ae3udal7uwi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

11 June 2018

http://europepmc.org/abstract/PMC/5461381

1 reference

Europe PubMed Central

11 June 2018

http://europepmc.org/abstract/PMC/5461381

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50597191&oldid=1835683808"